Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Identifying Therapeutic Targets of Accelerated Sarcopenia

Authors not listed

The University of Texas Medical Branch, Galveston · 2017

Abstract

The proposed research is designed to identify the mechanisms that can accelerate loss of muscle size, strength and physical function in type 2 diabetes and with hospitalization in older persons. About ⅓ of older Americans have type 2 diabetes, and about ⅓ of the hospitalizations in the USA involve persons older than 65 year of age. The proposed research is relevant to the part of NIH's mission that pertains to development of the fundamental knowledge that will improve health and reduce the burdens of disability, because this work will provide the fundamental evidence to identify new targets for the development of innovative treatments to slow down muscle loss and disability in our aging society.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-18 MST

Cite this

APA
Anonymous. (2017). Identifying Therapeutic Targets of Accelerated Sarcopenia. <em>The University of Texas Medical Branch, Galveston</em>. https://clinicaltrials.gov/study/NCT03118050
Vancouver
Anonymous. Identifying Therapeutic Targets of Accelerated Sarcopenia. The University of Texas Medical Branch, Galveston. 2017.
BibTeX
@misc{anon2017Identi, title = {Identifying Therapeutic Targets of Accelerated Sarcopenia}, author = {Anonymous}, journal = {The University of Texas Medical Branch, Galveston}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings